Drugs / ASP3550
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00568516 | Oct 2007 → Oct 2009 | prostate neoplasm | Astellas Pharma Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP3550 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00568516 ↗ |
| Route | Subcutaneous | “subcutaneous administration” NCT00568516 ↗ |